⌘K

Login Start Free

Home/Filings/4/0001437749-25-037164

4//SEC Filing

Vu Quan Anh 4

Accession 0001437749-25-037164

CIK 0001645469other

View on SEC.gov Company Profile

Filed

Dec 7, 7:00 PM ET

Accepted

Dec 8, 4:47 PM ET

Size

7.0 KB

Accession

0001437749-25-037164

Insider Transaction Report

Form 4

Period: 2025-12-02

Monopar TherapeuticsMNPR

Chief Financial Officer

Transactions

Award
Stock Options
2025-12-02+7,135→ 7,135 total
Exercise: $75.94Exp: 2035-12-02→ Common Stock (7,135 underlying)
Award
Restricted Stock Units
2025-12-02+9,826→ 9,826 total
Exercise: $0.00→ Common Stock (9,826 underlying)

Footnotes (2)

[F1]Options vest 6/48ths on June 30, 2026, and 1/48th per month thereafter.
[F2]RSUs vest 6/48ths on June 30, 2026, and 3/48ths per quarter thereafter.

Documents

1 file

4
rdgdoc.xmlPrimary
FORM 4

Issuer

Monopar Therapeutics

CIK 0001645469

Entity typeother

Related Parties

1

filerCIK 0001892297

Filing Metadata

Form type: 4
Filed: Dec 7, 7:00 PM ET
Accepted: Dec 8, 4:47 PM ET
Size: 7.0 KB

View on SEC.gov